Mackay jumps Pfizer ship to head AZ R&D

Pfizer this morning announced a big change at the top of its R&D empire as it continues to meld its development program with Wyeth's. Mikael Dolsten  (photo), M.D., PhD., the former head of Wyeth's R&D, has been named the global chief of Pfizer research and development while Martin Mackay (photo) leaves Pfizer to take the same job at AstraZeneca. Report